Montagu has sold VetXX, a developer, producer and marketer of companion animal veterinary products, to Dechra Pharmaceuticals. Dechra Pharmaceuticals is an international veterinary pharmaceutical business. In its most recent financial year Dechra enjoyed sales of £253.8m. The transaction is expected to complete in January 2008. Montagu was advised by PwC Corporate Finance and Accura Advokataktieselskab. Prior to the buyout by Montagu Private Equity in 2005, VetXX was known as Leo Animal Health.
To read the entire story, you must be logged in.
Please log in now or register with us.
